Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.
Alice WuChristine PhanKim Chi NguyenMelvin QuindoyJustin LewisDorie E ApollonioPublished in: Clinical toxicology (Philadelphia, Pa.) (2020)
DEA rescheduling of HCPs was associated with a significant reduction in prescription opioid exposures, suggesting that rescheduling high-risk drugs may be an effective strategy to improve public health.